SOUTH SAN FRANCISCO, Calif., Dec. 15, 2017 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the resignation of Ryan Maynard, executive vice president and chief financial officer, effective December 31, 2017. Nelson Cabatuan, Rigel’s vice president, finance wi…
